[Click eStock] "Nutri, Q2 Earnings Bottom Confirmed... Growth Trend Continues"

Daishin Securities Issues 'Buy' Investment Opinion and Sets Target Price at 39,000 Won... Closing Price on 2nd at 21,350 Won

[Asia Economy Reporter Kum Boryeong] Nutri is analyzed to have confirmed the bottom of its second-quarter performance.

According to Daishin Securities on the 3rd, Nutri's third-quarter performance is estimated at an operating profit of 5.7 billion KRW and sales of 45.2 billion KRW. Compared to the previous year, operating profit increased by 74.6% and sales by 34.4%. Compared to the previous quarter, they increased by 7.5% and 4.2%, respectively.

Han Kyungrae, a researcher at Daishin Securities, explained, "Since August, a rebound in collagen has been confirmed. This is influenced by the strong popularity of the additional lineup 'Evercollagen Time Biotin.' The Naver trend for Evercollagen increased by 127% in October compared to July. It is understood that the preemptive effect as the No.1 brand in the collagen market continues."

Last month, the functional probiotic Masterbiome's 'Skinmaster' was launched. The first broadcast sales on GS Home Shopping recorded a positive sales figure of about 400 million KRW. 'Gnomaster' is scheduled to be launched next month.

In the fourth quarter, performance is expected to increase further with the effect of new products. Daishin Securities forecasts Nutri's fourth-quarter performance at an operating profit of 6.2 billion KRW and sales of 47.2 billion KRW. This represents increases of 43.1% and 30.4%, respectively, compared to the previous year.

Daishin Securities gave Nutri a 'Buy' investment opinion and a target stock price of 39,000 KRW. The closing price on the 2nd was 21,350 KRW. The researcher said, "After the approval of the new individually recognized raw materials by the Ministry of Food and Drug Safety, we plan to launch products within the first half of next year. Considering the expansion of the new product lineup, next year's sales are expected to increase by 27.1% from this year to 231 billion KRW. Additional upward revisions of performance are possible in line with the full-scale overseas export and new product sales trends."